Procaps Gr Stock (NASDAQ: PROC) stock price, news, charts, stock research, profile.
Open | $1.87 |
Close | $1.68 |
Volume / Avg. | 6.45K / 5.35K |
Day Range | $1.68 - $1.87 |
52 Wk Range | 1.69 - 4.95 |
Market Cap | $224.52M |
P/E Ratio | 3.53 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 38 |
Short Interest | 0.03% |
Days to Cover | 6.67 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Procaps Gr (NASDAQ:PROC) through any online brokerage.
Other companies in Procaps Gr’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS), Esperion Therapeutics (NASDAQ:ESPR) and Telomir Pharmaceuticals (NASDAQ:TELO).
Procaps Gr has a consensus price target of $4.50.
The stock price for Procaps Gr (NASDAQ: PROC) is $1.99 last updated August 15, 2024 at 4:54 PM EDT.
There are no upcoming dividends for Procaps Gr.
Procaps Gr’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for Procaps Gr.
Procaps Gr is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.